Toll-like receptor 9 signaling is associated with immune responses to Trypanosoma brucei infection

Int Immunopharmacol. 2024 Jun 15:134:112250. doi: 10.1016/j.intimp.2024.112250. Epub 2024 May 14.

Abstract

Trypanosoma brucei, a causative agent of human and animal trypanosomiasis, regularly switches its major surface antigen to avoid elimination by the immune system. Toll-like receptor 9 (TLR9) is a key modulator for resistance to host-infective trypanosomes; however, the underlying molecular mechanism remains indistinct. Thus, we first approached the issue using Tlr9-mutant mice that render them non-responsive to TLR9 agonists. After infection, T cells in the spleens of Tlr9-mutant mice were analyzed by flow cytometry and a reduction in CD8+, CD4+ T, and NKT cells was observed in Tlr9-mutant mice compared to WT mice. We further found that the responses of inflammatory cytokines in the sera were reduced in Tlr9-mutant mice after T. brucei infection. The underlying molecular mechanism was that T. b. brucei DNA activated TLR9, which consequently upregulated the expression of p38 and ERK/MAPK, resulting in host resistance to trypanosome infection. In conclusion, these findings provide novel insights into the TLR9-mediated host responses to trypanosome infection.

Keywords: Inflammation; MAPK; T cells; TLR9; Trypanosoma brucei.

MeSH terms

  • Animals
  • Cytokines* / metabolism
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Signal Transduction*
  • Toll-Like Receptor 9* / agonists
  • Toll-Like Receptor 9* / metabolism
  • Trypanosoma brucei brucei* / immunology
  • Trypanosomiasis, African* / immunology

Substances

  • Toll-Like Receptor 9
  • Tlr9 protein, mouse
  • Cytokines